Celldex Therapeutics, Inc. - FORM 10-K - EX-32 - EXHIBIT 32 - March 12, 2010

Attached files

file filename
10-K - 10-K - Celldex Therapeutics, Inc.a2196680z10-k.htm
EX-4.5 - EXHIBIT 4.5 - Celldex Therapeutics, Inc.a2196680zex-4_5.htm
EX-23.1 - EXHIBIT 23.1 - Celldex Therapeutics, Inc.a2196680zex-23_1.htm
EX-21.0 - EXHIBIT 21.0 - Celldex Therapeutics, Inc.a2196680zex-21_0.htm
EX-31.2 - EXHIBIT 31.2 - Celldex Therapeutics, Inc.a2196680zex-31_2.htm
EX-23.2 - EXHIBIT 23.2 - Celldex Therapeutics, Inc.a2196680zex-23_2.htm
EX-31.1 - EXHIBIT 31.1 - Celldex Therapeutics, Inc.a2196680zex-31_1.htm
EX-10.35 - EXHIBIT 10.35 - Celldex Therapeutics, Inc.a2196680zex-10_35.htm
EX-10.28 - EXHIBIT 10.28 - Celldex Therapeutics, Inc.a2196680zex-10_28.htm
EX-10.42 - EXHIBIT 10.42 - Celldex Therapeutics, Inc.a2196680zex-10_42.htm
EX-10.29 - EXHIBIT 10.29 - Celldex Therapeutics, Inc.a2196680zex-10_29.htm
EX-10.30 - EXHIBIT 10.30 - Celldex Therapeutics, Inc.a2196680zex-10_30.htm
EX-10.27 - EXHIBIT 10.27 - Celldex Therapeutics, Inc.a2196680zex-10_27.htm
EX-10.41 - EXHIBIT 10.41 - Celldex Therapeutics, Inc.a2196680zex-10_41.htm
EX-10.34 - EXHIBT 10.34 - Celldex Therapeutics, Inc.a2196680zex-10_34.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 32

        The undersigned officers of Celldex Therapeutics, Inc. (the "Company") hereby certify to our knowledge that the Company's annual report on Form 10-K to which this certification is attached (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 12, 2010   By:   /s/ ANTHONY S. MARUCCI
        Name:   Anthony S. Marucci
        Title:   President and Chief Executive Officer

Date: March 12, 2010
 
By:
 
/s/ AVERY W. CATLIN
        Name:   Avery W. Catlin
        Title:   Senior Vice President and
Chief Financial Officer

        This certification shall be not be deemed "filed" for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act.



QuickLinks

Celldex Therapeutics, Inc. Reports